pembrolizumab as adjuvant therapy for patients with renal cell carcinoma
Published 2 years ago • 392 plays • Length 6:41Download video MP4
Download video MP3
Similar videos
-
5:33
keynote-564: pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with...
-
1:03
potential of adjuvant therapy for rcc
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
3:01
a phase iii trial of pembrolizumab as adjuvant treatment for renal cell carcinoma
-
2:22
adjuvant pembrolizumab and survival in renal-cell carcinoma | nejm
-
1:00
adjuvant pembrolizumab in kidney cancer from keynote 564
-
0:35
the latest developments in adjuvant therapy for rcc
-
4:33
emerging data on adjuvant therapy for rcc
-
2:18
dr. pal discusses adjuvant therapy for renal cell carcinoma
-
0:53
the role of icis in the adjuvant setting for rcc
-
0:55
selecting patients with renal cell carcinoma for adjuvant sunitinib therapy
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
3:30
individualized axitinib dosing for patients with metastatic renal cell carcinoma
-
0:43
dr. rini on adjuvant immunotherapy in renal cell carcinoma
-
9:29
keynote-564 study
-
1:11
current standard of adjuvant therapy in kidney cancer
-
32:22
auau podcast: adjuvant therapy in renal cell carcinoma
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer